C/A 0001787792 XXXXXXXX 020-37002 LIVE false false false false Correction to "principal equity holders" chart; addition of compensation information for "directors, executive officers, and significant employees" Fisher Wallace Laboratories, Inc. Corporation DE 08-23-2019 630 FLUSHING AVENUE, BOX 104 BROOKLYN OH 11206 fisherwallace.com N DEALMAKER SECURITIES LLC 0001872856 008-70756 000315324 Up to 8.5% Common Stock 900 11.30000 10525.95 Y Other At the discretion of the Company 4398747.72 07-31-2026 3.00 144634.00 154382.00 48142.00 41626.00 0.00 0.00 591311.00 596721.00 693612.00 925582.00 34261.00 47412.00 5049.00 3012.00 0.00 0.00 -1447538.00 -1579900.00 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY A0 A1 A2 A3 A4 A5 A6 A7 A8 A9 B0 Z4 Fisher Wallace Laboratories, Inc. /Kelly Roman/ Chief Executive Officer and Director /Kelly Roman/ Chief Executive Officer and Director 05-22-2026